AGG

AGG prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation.

Medicinal name:
  • Aspirin 25 MG / Dipyridamole 200 MG Oral Capsule [Aggrenox]

AGG - Pharmacology:

AGG is a reversible antagonist of fibrinogen binding to the GP IIb/IIIa receptor, the major platelet surface receptor involved in platelet aggregation. Platelet aggregation inhibition is reversible following cessation of the infusion of AGG.

AGG for patients

Follow all instructions for proper mixing or dilution (if necessary) and refer to the tirofiban dosing chart for the recommended IV dosing. If you have questions regarding the use of this medication, consult your pharmacist. Give this medication by vein (IV) as an initial dose (bolus dose) followed by an IV infusion as directed by your doctor. The dosage is based on your weight, medical condition, and response to therapy. Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid. Learn how to store and discard needles and medical supplies safely. Consult your pharmacist.

AGG Interactions

AGGRASTAT has been studied on a background of aspirin and heparin.

The use of AGGRASTAT, in combination with heparin and aspirin, has been associated with an increase in bleeding compared to heparin and aspirin alone (see

AGG Contraindications

AGGRASTAT is contraindicated in patients with:

ï known hypersensitivity to any component of the product

ï active internal bleeding or a history of bleeding diathesis within the previous 30 days

ï a history of intracranial hemorrhage, intracranial neoplasm, arteriovenous malformation, or aneurysm

ï a history of thrombocytopenia following prior exposure to AGGRASTAT

ï history of stroke within 30 days or any history of hemorrhagic stroke

ï major surgical procedure or severe physical trauma within the previous month

ï history, symptoms, or findings suggestive of aortic dissection

ï severe hypertension (systolic blood pressure >180 mmHg and/or diastolic blood pressure >110 mmHg)

ï concomitant use of another parenteral GP IIb IIIa inhibitor

ï acute pericarditis

Manufacturers name:

  • Carilion Materials Management
  • Rebel Distributors Corp
  • Boehringer Ingelheim Pharmaceuticals, Inc
  • Physicians Total Care, Inc

Generic name, Overdose, Half Life AGG, Food Interactions, Chemical, etc..

AGG see also FDA report Catuaba

Brand Names containing Tirofiban
Cardiovascular-diseases